Blueprint Medicines shares owned by Vanguard Group
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $564M | 6.1M | 92.24 |
| 2023-09-30 | $300M | 6.0M | 50.22 |
| 2023-06-30 | $375M | 5.9M | 63.20 |
| 2023-03-31 | $265M | 5.9M | 44.99 |
| 2022-12-31 | $253M | 5.8M | 43.81 |
| 2022-06-30 | $284M | 5.6M | 50.51 |
| 2022-03-31 | $353M | 5.5M | 63.88 |
| 2021-09-30 | $574M | 5.6M | 102.81 |
| 2021-06-30 | $490M | 5.6M | 87.96 |
| 2021-03-31 | $536M | 5.5M | 97.23 |
| 2020-12-31 | $582M | 5.2M | 112.15 |
| 2020-09-30 | $445M | 4.8M | 92.70 |
| 2020-06-30 | $385M | 4.9M | 78.00 |
| 2020-03-31 | $285M | 4.9M | 58.48 |
| 2019-12-31 | $350M | 4.4M | 80.11 |
| 2019-09-30 | $319M | 4.3M | 73.48 |
| 2019-03-31 | $317M | 4.0M | 80.04 |
| 2018-12-31 | $206M | 3.8M | 53.87 |
| 2018-09-30 | $292M | 3.7M | 78.06 |
| 2018-06-30 | $230M | 3.6M | 63.48 |
| 2018-03-31 | $310M | 3.4M | 91.70 |
| 2017-12-31 | $250M | 3.3M | 75.41 |
| 2017-09-30 | $135M | 1.9M | 69.81 |
| 2017-06-30 | $72M | 1.4M | 50.66 |
| 2017-03-31 | $49M | 1.2M | 39.99 |
| 2016-12-31 | $26M | 907k | 28.57 |
| 2016-09-30 | $21M | 713k | 29.69 |
| 2016-06-30 | $12M | 567k | 20.25 |
| 2015-12-31 | $13M | 505k | 26.33 |
| 2015-09-30 | $4.6M | 216k | 21.31 |
| 2015-06-30 | $4.9M | 185k | 26.51 |